Follow
Thomas Jaki
Thomas Jaki
Professor of Statistics and Programme Leader at MRC Biostatistics Unit
Verified email at mrc-bsu.cam.ac.uk - Homepage
Title
Cited by
Cited by
Year
Dexamethasone in hospitalized patients with Covid-19.
P Horby, WS Lim, JR Emberson, M Mafham, JL Bell, L Linsell, N Staplin, ...
N Engl J Med, 693-704, 2021
7111*2021
A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19
B Cao, Y Wang, D Wen, W Liu, J Wang, G Fan, L Ruan, B Song, Y Cai, ...
New England Journal of Medicine, 2020
58332020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Y Wang, D Zhang, G Du, R Du, J Zhao, Y Jin, S Fu, L Gao, Z Cheng, Q Lu, ...
The Lancet 395 (10236), 1569-1578, 2020
35972020
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 397 (10285), 1637-1645, 2021
1358*2021
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
P Horby, M Mafham, L Linsell, JL Bell, N Staplin, JR Emberson, M Wiselka, ...
The New England journal of medicine, 2020
12542020
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, M Mafham, JL Bell, L Linsell, N Staplin, J Emberson, ...
The Lancet 396 (10259), 1345-1352, 2020
6462020
Adaptive designs in clinical trials: why use them, and how to run and report them
P Pallmann, AW Bedding, B Choodari-Oskooei, M Dimairo, L Flight, ...
BMC medicine 16 (1), 1-15, 2018
3882018
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, A Roddick, E Spata, N Staplin, J Emberson, G Pessoa-Amorim, ...
Lancet 397 (10274), 605-612, 2021
2682021
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, G Pessoa-Amorim, N Staplin, JR Emberson, M Campbell, ...
Lancet 399 (10320), 143-151, 2022
190*2022
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, L Estcourt, L Peto, JR Emberson, N Staplin, E Spata, ...
Lancet 397 (10289), 2049-2059, 2021
1762021
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet, 2021
1502021
A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection
D Magirr, T Jaki, J Whitehead
Biometrika 99 (2), 494-501, 2012
1352012
Probabilistic relabelling strategies for the label switching problem in Bayesian mixture models
M Sperrin, T Jaki, E Wit
Statistics and Computing 20 (3), 357-366, 2010
1162010
Assessing differential effects: Applying regression mixture models to identify variations in the influence of family resources on academic achievement.
ML Van Horn, T Jaki, K Masyn, SL Ramey, JA Smith, S Antaramian
Developmental psychology 45 (5), 1298, 2009
1092009
A review of statistical updating methods for clinical prediction models
TL Su, T Jaki, GL Hickey, I Buchan, M Sperrin
Statistical methods in medical research 27 (1), 185-197, 2018
1052018
Optimal design of multi‐arm multi‐stage trials
J Wason, T Jaki
Statistics in Medicine 31 (30), 4269-4279, 2012
1032012
Some recommendations for multi-arm multi-stage trials
J Wason, D Magirr, M Law, T Jaki
Statistical methods in medical research 25 (2), 716-727, 2016
842016
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
The Lancet Respiratory Medicine 9 (12), 1419-1426, 2021
822021
Differential effects of parental controls on adolescent substance use: For whom is the family most important?
AA Fagan, ML Van Horn, J David Hawkins, T Jaki
Journal of quantitative criminology 29, 347-368, 2013
782013
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study
SH Khoo, R Fitzgerald, T Fletcher, S Ewings, T Jaki, R Lyon, N Downs, ...
Journal of Antimicrobial Chemotherapy, 2021
772021
The system can't perform the operation now. Try again later.
Articles 1–20